Status:
UNKNOWN
Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac Functions
Lead Sponsor:
Ornit Cohen
Conditions:
Attention Deficit Disorder With Hyperactivity
Attention Deficit Disorder
Eligibility:
All Genders
8-18 years
Brief Summary
The purpose of this study is to find out whether prolonged treatment with methylphenidate has any adverse effect on cardiac functions and measurements.
Detailed Description
Attention deficit hyperactivity disorder (ADHD) is the most common neurobehavioral condition of childhood, with symptoms consisting of inattentiveness, impulsivity and hyperactivity. The diagnosis rel...
Eligibility Criteria
Inclusion
- Children with ADHD aged 8-18 years who are taking methylphenydate (Ritalin©, Ritalin SR©, Ritalin LA©) for more than 5 years.
Exclusion
- Children with any known heart disease or anomaly. Children whose ADHD is part of a syndrome or are mentally retarded. Children that are on any other chronic medications.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00372359
Start Date
August 1 2006
End Date
December 1 2012
Last Update
September 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Day Care Center, The Barzilai Medical Center
Ashkelon, Israel, 78306